Evergreen Theragnostics

About:

Evergreen Theragnostics is a contract development and manufacturing platform that provides radiopharmaceutical development services.

Website: https://evergreentgn.com/

Top Investors: Club degli Investitori, Petrichor Healthcare Capital Management, LIFTT

Description:

Evergreen Theragnostics is a contract development and manufacturing platform that provides radiopharmaceutical development services. Founded in 2019, Evergreen Theragnostics rose to prominence as a notable Contract Development and Manufacturing Organization (CDMO) specializing in radiopharmaceuticals within the United States. Benefiting from an unmatched team with extensive expertise and a demonstrated track record in theragnostic radiopharmaceutical commercialization, advancement of manufacturing processes, and management of regulatory affairs, the organization stands as an ideal partner for radiopharmaceutical development, manufacturing, and commercialization needs.

Total Funding Amount:

$60M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Jersey City, New Jersey, United States

Founded Date:

2019-01-01

Founders:

James Cook, Serge Lyashchenko

Number of Employees:

11-50

Last Funding Date:

2024-04-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai